These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 14407473)

  • 1. Prothrombin utilization following addition of platelet confactor I concentrates to hemophilic plasma.
    JOHNSON JF; MAMMEN EF; SEEGERS WH
    Thromb Diath Haemorrh; 1959 Sep; 3():588-92. PubMed ID: 14407473
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of purified prothrombin with hemophilic plasma.
    JOHNSON SA
    Am J Clin Pathol; 1953 Sep; 23(9):875-80. PubMed ID: 13092058
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prothrombin level in hemophilic blood and in hemophilic-like blood after the addition in vitro of fresh normal blood].
    TROPEANO L
    Boll Soc Ital Biol Sper; 1952 Dec; 28(12):1890-2. PubMed ID: 13059108
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of coagulase-globulin on residual prothrombin activity (prothrombin consumption) of hemophilic blood.
    MIALE JB; WENZEL FJ
    Proc Soc Exp Biol Med; 1952 May; 80(1):76-7. PubMed ID: 14930078
    [No Abstract]   [Full Text] [Related]  

  • 5. Interaction of convertin with platelets and with platelet-free and hemophilic plasma.
    DE VRIES A; KREJNIS E; SHAFRIR E
    Acta Haematol; 1956 Sep; 16(3):204-13. PubMed ID: 13354260
    [No Abstract]   [Full Text] [Related]  

  • 6. Prothrombin and the one-stage prothrombin time.
    QUICK AJ; HUSSEY CV
    Br Med J; 1955 Apr; 1(4919):934-7. PubMed ID: 14363752
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prothrombin level in hemophilic blood after the addition in vitro of Cohn's fraction Ia (antihemophilic globulin)].
    TROPEANO L
    Boll Soc Ital Biol Sper; 1952 Dec; 28(12):1892-4. PubMed ID: 13059109
    [No Abstract]   [Full Text] [Related]  

  • 8. Clotting of hemophilic blood with purified platelet cofactor I, platelet factor 3 and threone.
    SEEGERS WH; LANDABURU RH; HOLBURN RR; TOCANTINS LM
    Proc Soc Exp Biol Med; 1957 Jul; 95(3):583-5. PubMed ID: 13453515
    [No Abstract]   [Full Text] [Related]  

  • 9. Assay of antihaemophilic factor using the prothrombin conversion ratio.
    WOLF P
    Br J Haematol; 1956 Oct; 2(4):386-96. PubMed ID: 13383105
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of platelets on the in vitro response to prothrombin complex concentrates in F.VIII inhibitor plasma.
    Castaldi PA; Smith IL
    Pathology; 1980 Jan; 12(1):111-8. PubMed ID: 6769085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombelastographic observations on the characteristics of hemophilic, thrombocytopenic and heparinized blood.
    DE NICOLA P; MAZZETTI GM
    Blood; 1956 Jan; 11(1):71-80. PubMed ID: 13276486
    [No Abstract]   [Full Text] [Related]  

  • 12. Failure of transfusion of hemophilic plasma to induce abnormalities of hemostatic mechanism in normal individuals.
    STEFANINI M; CHATTERJEA JB; SALOMON L
    Proc Soc Exp Biol Med; 1951 Oct; 78(1):274-7. PubMed ID: 14891990
    [No Abstract]   [Full Text] [Related]  

  • 13. [The so-called prothrombin consumption test in hemophilia (in the male and the carrier) and in Willebrand-Jergens constitutional thrombopathy].
    JURGENS R; FERLIN A
    Schweiz Med Wochenschr; 1950 Oct; 80(41):1098-101. PubMed ID: 14787382
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of snake venoms on prothrombin time of normal and hemophiliac blood.
    MACHT DI
    Fed Proc; 1946; 5(1 Pt 2):68. PubMed ID: 21066385
    [No Abstract]   [Full Text] [Related]  

  • 15. Antihemophilic factor (AHF): plasma levels after administration of AHF preparations to hemophilic dogs.
    WAGNER RH; LANGDELL RD; RICHARDSON BA; FARRELL RA; BRINKHOUS KM
    Proc Soc Exp Biol Med; 1957 Oct; 96(1):152-5. PubMed ID: 13485042
    [No Abstract]   [Full Text] [Related]  

  • 16. Clotting defect in hemophilia; deficiency in a plasma factor required for thromboplastin liberation from platelets.
    BRINKHOUS KM
    Fed Proc; 1947; 6(1):389. PubMed ID: 20343817
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the incomplete correction of the hemophilic hemocoagulative error on the part of conductor blood. Thromboelastographic observations].
    GIACCA S; NEGRINI AC
    Arch Maragliano Patol Clin; 1959 Aug; 15():1071-80. PubMed ID: 13827794
    [No Abstract]   [Full Text] [Related]  

  • 18. [The reaction of factor V in the serum under normal and pathological conditions].
    KAPPELER R
    Z Klin Med; 1955; 153(2):103-13. PubMed ID: 13248049
    [No Abstract]   [Full Text] [Related]  

  • 19. Variation in the reducing power of plasma and serum in hypoprothrombinemia and hemophilia.
    PALOS LA
    Thromb Diath Haemorrh; 1960 Mar; 4():276-82. PubMed ID: 14430036
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical, clinical and immunological studies on the products of human plasma fractionation; the coagulation defect in hemophilia; the effect in vitro and in vivo on the coagulation time in hemophilia of a prothrombin and fibrinogen-free normal plasma and its derived protein fractions.
    LEWIS JH; SOULIER JP; TAYLOR FH
    J Clin Invest; 1946 Nov; 25(6):876-9. PubMed ID: 20282730
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.